NextCell Pharma AB (NXTCL.XSTO) Financials
All currency values in kr millions unless otherwise noted
Scroll
| Income Statement | DEC 2025 | AUG 2024 | AUG 2023 | AUG 2022 | AUG 2021 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | kr 10 | kr 11 | kr 10 | kr 6 | kr 4 |
| Cost of Revenue | kr 8 | kr 15 | kr 11 | kr 9 | kr 18 |
| Gross Profit | kr 2 | -kr 5 | -kr 1 | -kr 3 | -kr 15 |
| Total Operating Expenses | kr 42 | kr 39 | kr 40 | kr 32 | kr 10 |
| Operating Income | -kr 40 | -kr 43 | -kr 41 | -kr 35 | -kr 25 |
| Non-Operating | |||||
| Net Interest Expense | -kr 0 | -kr 0 | -kr 0 | -kr 0 | -kr 0 |
| Income Tax Expense | kr 0 | kr 0 | kr 0 | kr 0 | kr 0 |
| Net Income | |||||
| Net Income | -kr 39 | -kr 42 | -kr 40 | -kr 35 | -kr 25 |
| Per Share Data | |||||
| Revenue Per Share | kr 0.24 | kr 0.26 | kr 0.23 | kr 0.13 | kr 0.09 |
| EPS (Basic) | -kr 0.96 | -kr 1.03 | -kr 0.91 | -kr 0.82 | -kr 0.56 |
| EPS (Diluted) | -kr 0.96 | -kr 1.03 | -kr 0.91 | -kr 0.82 | -kr 0.56 |
| Shares Outstanding | 40.8M | 40.8M | 43.5M | 43.5M | 43.5M |
NextCell Pharma AB (NXTCL.XSTO) financials: revenue, profit and margins
NextCell Pharma AB (NXTCL.XSTO) generated about SEK 10 million in revenue and -SEK 39 million in net income (a -395.2% net margin) over the trailing twelve months, growing at roughly 26.3% a year. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is NextCell Pharma AB's (NXTCL.XSTO) revenue?+
NextCell Pharma AB generated about SEK 10 million in revenue over the trailing twelve months. Revenue has grown at roughly 26.3% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is NextCell Pharma AB profitable?+
NextCell Pharma AB reported about -SEK 39 million in net loss over the trailing twelve months, a net margin of roughly -395.2%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are NextCell Pharma AB's profit margins?+
NextCell Pharma AB runs a gross margin of about 16.4%, an operating margin of about -401.3%, a net margin of about -395.2%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is NextCell Pharma AB growing?+
NextCell Pharma AB's revenue has compounded at roughly 26.3% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside NXTCL.XSTO's margins and free cash flow. This is analysis from company filings, not investment advice.
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.